Loomis, Sayles & Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $675M | Buy |
|
|||||
|
2025
Q1 | $613M | Sell |
|
|||||
|
2024
Q4 | $543M | Sell |
|
|||||
|
2024
Q3 | $664M | Sell |
|
|||||
|
2024
Q2 | $633M | Buy |
|
|||||
|
2024
Q1 | $572M | Sell |
|
|||||
|
2023
Q4 | $607M | Sell |
|
|||||
|
2023
Q3 | $618M | Sell |
|
|||||
|
2023
Q2 | $637M | Sell |
|
|||||
|
2023
Q1 | $608M | Sell |
|
|||||
|
2022
Q4 | $993M | Sell |
|
|||||
|
2022
Q3 | $1.13B | Sell |
|
|||||
|
2022
Q2 | $1.31B | Sell |
|
|||||
|
2022
Q1 | $1.52B | Sell |
|
|||||
|
2021
Q4 | $1.57B | Sell |
|
|||||
|
2021
Q3 | $1.55B | Sell |
|
|||||
|
2021
Q2 | $1.74B | Sell |
|
|||||
|
2021
Q1 | $1.69B | Sell |
|
|||||
|
2020
Q4 | $1.9B | Buy |
|
|||||
|
2020
Q3 | $914M | Sell |
|
|||||
|
2020
Q2 | $921M | Buy |
|
|||||
|
2020
Q1 | $858M | Buy |
|
|||||
|
2019
Q4 | $972M | Buy |
|
|||||
|
2019
Q3 | $617M | Buy |
|
|||||
|
2019
Q2 | $642M | Sell |
|
|||||
|
2019
Q1 | $674M | Buy |
|
|||||
|
2018
Q4 | $598M | Sell |
|
|||||
|
2018
Q3 | $633M | Buy |
|
|||||
|
2018
Q2 | $545M | Sell |
|
|||||
|
2018
Q1 | $631M | Buy |
|
|||||
|
2017
Q4 | $581M | Buy |
|
|||||
|
2017
Q3 | $584M | Buy |
|
|||||
|
2017
Q2 | $554M | Buy |
|
|||||
|
2017
Q1 | $464M | Buy |
|
|||||
|
2016
Q4 | $452M | Buy |
|
|||||
|
2016
Q3 | $462M | Buy |
|
|||||
|
2016
Q2 | $462M | Buy |
|
|||||
|
2016
Q1 | $380M | Buy |
|
|||||
|
2015
Q4 | $416M | Buy |
|
|||||
|
2015
Q3 | $423M | Buy |
|
|||||
|
2015
Q2 | $421M | Buy |
|
|||||
|
2015
Q1 | $356M | Buy |
|
|||||
|
2014
Q4 | $324M | Buy |
|
|||||
|
2014
Q3 | $323M | Buy |
|
|||||
|
2014
Q2 | $277M | Buy |
|
|||||
|
2014
Q1 | $245M | Buy |
|
|||||
|
2013
Q4 | $163M | Buy |
|
|||||
|
2013
Q3 | $154M | Buy |
|
|||||
|
2013
Q2 | $61.1K | Buy |
|